A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion
- PMID: 14982604
- DOI: 10.1111/j.1440-1843.2003.00521.x
A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion
Abstract
Objective: The aim of this study was to determine the validity of pleural fluid C-reactive protein (CRP) concentrations and/or pleural fluid to serum CRP ratio for differentiating tuberculous pleuritis (TBP) from malignant pleural effusion (MPE) in patients presenting with lymphocytic exudative pleural effusions.
Methodology: A cross-sectional study was conducted on 161 patients with pleural effusion who underwent diagnostic evaluation at Siriraj Hospital, Bangkok, Thailand, between April 2001 and March 2002. The complete biochemical analysis of pleural fluid, cultures of pleural fluid, and pathological examinations of pleural fluid and pleural tissue were performed. The CRP concentrations were then measured in stored sera and pleural fluid samples from patients with a lymphocytic exudative pleural effusion and with a definite diagnosis.
Results: Among the 148 patients with lymphocytic exudative pleural effusions, 55 were diagnosed with TBP, 60 with MPE, and 33 with non-specific pleuritis. Pleural fluid and serum CRP levels were significantly higher in the TBP group than in the MPE group (54.58 +/- 4.50 mg/L and 106.93 +/- 9.54 mg/L vs 12.66 +/- 3.52 mg/L and 49.66 +/- 8.84 mg/L, respectively, P < 0.001). The ratio of pleural fluid to serum CRP was significantly higher in the TBP group than in the MPE group (0.52 +/- 0.18 vs 0.30 +/- 0.16, P < 0.001). The optimum cut-off value for pleural fluid CRP level of > or =30 mg/dL had a sensitivity of 72% with 93% specificity, and the pleural fluid to serum CRP ratio cut-off value of 0.45 had a sensitivity of 60% with 89% specificity. A correlation between serum and pleural fluid CRP levels was observed in TBP patients but not in MPE patients.
Conclusion: In patients presenting with lymphocytic exudative pleural effusion, a simple marker of raised pleural fluid CRP level may be helpful in discriminating between TBP and MPE.
Comment in
-
A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion: comment.Respirology. 2004 Nov;9(4):568; author reply 569. doi: 10.1111/j.1440-1843.2004.00639.x. Respirology. 2004. PMID: 15612973 No abstract available.
Similar articles
-
Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.Eur J Med. 1992 Jul-Aug;1(4):201-7. Eur J Med. 1992. PMID: 1341445
-
Antibody detection for the diagnosis of tuberculous pleuritis.Int J Tuberc Lung Dis. 2001 Oct;5(10):968-72. Int J Tuberc Lung Dis. 2001. PMID: 11605893
-
Acute phase markers for the differentiation of infectious and malignant pleural effusions.Respir Med. 2007 May;101(5):910-8. doi: 10.1016/j.rmed.2006.09.019. Epub 2007 Jan 31. Respir Med. 2007. PMID: 17270413
-
Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.QJM. 2007 Jun;100(6):351-9. doi: 10.1093/qjmed/hcm032. QJM. 2007. PMID: 17525131 Review.
-
Useful tests on the pleural fluid in the management of patients with pleural effusions.Curr Opin Pulm Med. 1999 Jul;5(4):245-9. doi: 10.1097/00063198-199907000-00012. Curr Opin Pulm Med. 1999. PMID: 10407695 Review.
Cited by
-
The Diagnostic Value of the Pleural Fluid C-Reactive Protein in Parapneumonic Effusions.Dis Markers. 2016;2016:7539780. doi: 10.1155/2016/7539780. Epub 2016 Apr 18. Dis Markers. 2016. PMID: 27194820 Free PMC article. Clinical Trial.
-
Tumor necrosis factor alpha and high sensitivity C-reactive protein in diagnosis of exudative pleural effusion.J Res Med Sci. 2011 Nov;16(11):1405-9. J Res Med Sci. 2011. PMID: 22973340 Free PMC article.
-
Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.Pleura Peritoneum. 2021 Apr 19;6(2):83-90. doi: 10.1515/pp-2021-0111. eCollection 2021 Jun. Pleura Peritoneum. 2021. PMID: 34179342 Free PMC article.
-
Development and Validation of a Scoring System for Differential Diagnosis of Tuberculosis and Metastatic Tumor in the Spine.Infect Drug Resist. 2021 Feb 4;14:407-413. doi: 10.2147/IDR.S298316. eCollection 2021. Infect Drug Resist. 2021. PMID: 33574681 Free PMC article.
-
Diagnostic Efficacy of C-Reactive Protein in Differentiating Various Causes of Exudative Pleural Effusion: Disease Research Should Not Be Exclusive to the Wealthy.Adv Respir Med. 2025 Aug 5;93(4):29. doi: 10.3390/arm93040029. Adv Respir Med. 2025. PMID: 40862701 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous